Inhibition of SARS-CoV-2-Mediated Thromboinflammation by CLEC2.Fc

Scientists found that the spleen tyrosine kinase-coupled C-type lectin member 2 (CLEC2), which was highly expressed in platelets and alveolar macrophages, interacted with the receptor-binding domain of SARS-CoV-2 spike protein directly.